Guideline Summary: Evaluation of Severely Dilated Pulmonary Artery with Mild Pulmonary Hypertension

Differential Diagnosis

• Pulmonary valve stenosis is the most likely cause when a markedly enlarged main pulmonary artery coexists with mild or absent pulmonary hypertension. 1
• Isolated valvular pulmonary stenosis does not generate pulmonary arterial hypertension; the presence of PAH should prompt search for associated lesions such as atrial septal defect, peripheral pulmonary‑artery stenosis, or late ventricular‑septal‑defect closure with pulmonary vascular disease. 1
• Post‑stenotic dilation downstream of a pulmonary valve stenosis can produce pronounced pulmonary‑artery enlargement without elevated distal pressures. 1
• Pulmonary‑artery aneurysm should be suspected when the main pulmonary‑artery diameter exceeds 40–50 mm; it may cause compressive symptoms such as angina (left‑main coronary artery compression), hoarseness (recurrent laryngeal‑nerve compression), or wheeze (large‑airway compression). 2
• Pulmonary‑artery aneurysm carries a life‑threatening risk of rupture or dissection leading to cardiac tamponade. 2
• Chronic thromboembolic pulmonary hypertension (CTEPH) must be excluded in any patient with unexplained pulmonary hypertension and pulmonary‑artery dilation, because it is potentially curable with pulmonary endarterectomy or balloon pulmonary angioplasty. 5
• Ventilation‑perfusion (V/Q) scanning is more sensitive than computed tomography for detecting CTEPH and is mandatory before invasive evaluation. 5
• Pulmonary veno‑occlusive disease (PVOD) should be suspected when pulmonary‑artery dilation is disproportionate to hemodynamic severity and the diffusing capacity for carbon monoxide (DLCO) is severely reduced (< 45 % predicted). 2
• High‑resolution CT findings that strongly support PVOD include diffuse central ground‑glass opacification, interlobular septal thickening, mediastinal lymphadenopathy, pleural abnormalities, and effusions. 5
• Digital clubbing is atypical for idiopathic pulmonary arterial hypertension and raises suspicion for PVOD, cyanotic congenital heart disease, interstitial lung disease, or hepatic disease. 3

Diagnostic Imaging and Functional Testing

• Transthoracic Doppler echocardiography is the first‑line study to evaluate right‑ventricular size, function, estimated pulmonary‑artery systolic pressure, valvular lesions, and intracardiac shunts; a main pulmonary‑artery diameter ≥ 29 mm or a PA‑to‑aortic ratio ≥ 1.0 is highly specific for pulmonary hypertension. 2
• Contrast‑enhanced CT angiography accurately delineates CTEPH lesions (obstruction, webs, bands, intimal irregularities), measures pulmonary‑artery aneurysm dimensions, and identifies PVOD‑related high‑resolution CT features. 5
• Cardiac magnetic resonance imaging provides precise quantification of right‑ventricular volume, mass, and function, and can detect congenital heart disease when echocardiography is inconclusive. 5
• Pulmonary function testing with DLCO measurement is essential; a DLCO < 45 % predicted correlates with poor prognosis and suggests PVOD or systemic‑sclerosis‑associated PAH. 2

Hemodynamic Assessment

• Right‑heart catheterization is required for definitive diagnosis; a mean pulmonary‑artery pressure > 20 mmHg defines pulmonary hypertension, with pre‑capillary disease characterized by pulmonary‑artery wedge pressure ≤ 15 mmHg and pulmonary‑vascular resistance > 2 Wood units. 1
• During catheterization, measurement of gradients above, at, and below the pulmonary valve confirms or excludes significant pulmonary‑valve stenosis. 1
• RV angiography evaluates contractile function, infundibular obstruction, and valve mobility; pulmonary angiography assesses regurgitation and branch‑level stenoses. 1

Clinical Management Pitfalls

• Assuming that any marked pulmonary‑artery dilation equals severe idiopathic pulmonary arterial hypertension can miss alternative diagnoses such as pulmonary‑valve stenosis, aneurysm, or CTEPH. 1
• Omitting a V/Q scan may lead to missed CTEPH, a potentially curable condition; CT alone is insufficient. 5
• Misdiagnosing PVOD as idiopathic PAH can be fatal because pulmonary‑vasodilator therapy may precipitate life‑threatening pulmonary edema; high‑resolution CT and markedly reduced DLCO are key discriminators. 5

Urgent Referral Indications

• Immediate referral to a pulmonary‑hypertension center is warranted for patients with exertional syncope, rapidly worsening symptoms, signs of right‑heart failure (elevated jugular venous pressure, hepatomegaly, ascites, peripheral edema), or echocardiographic evidence of severe pulmonary hypertension or right‑ventricular dysfunction. 8
• Suspected mechanical complications of a pulmonary‑artery aneurysm (e.g., hoarseness, angina, hemoptysis suggesting compression or rupture) also mandate urgent specialist referral. 2